chr2-169493802-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2

The NM_152384.3(BBS5):​c.584A>G​(p.Asp195Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00137 in 1,611,756 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. D195D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0018 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 46 hom. )

Consequence

BBS5
NM_152384.3 missense

Scores

1
11
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 9.32

Publications

3 publications found
Variant links:
Genes affected
BBS5 (HGNC:970): (Bardet-Biedl syndrome 5) This gene encodes a protein that has been directly linked to Bardet-Biedl syndrome. The primary features of this syndrome include retinal dystrophy, obesity, polydactyly, renal abnormalities and learning disabilities. Experimentation in non-human eukaryotes suggests that this gene is expressed in ciliated cells and that it is required for the formation of cilia. Alternate transcriptional splice variants have been observed but have not been fully characterized. [provided by RefSeq, Jul 2008]
BBS5 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P
  • BBS5-related ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 7 curated pathogenic missense variants (we use a threshold of 10). The gene has 1 curated benign missense variants. Gene score misZ: 0.85025 (below the threshold of 3.09). Trascript score misZ: 1.0056 (below the threshold of 3.09). GenCC associations: The gene is linked to Bardet-Biedl syndrome 5, Bardet-Biedl syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.011274219).
BP6
Variant 2-169493802-A-G is Benign according to our data. Variant chr2-169493802-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 96498.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00183 (279/152352) while in subpopulation AMR AF = 0.0156 (239/15306). AF 95% confidence interval is 0.014. There are 4 homozygotes in GnomAd4. There are 133 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_152384.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BBS5
NM_152384.3
MANE Select
c.584A>Gp.Asp195Gly
missense
Exon 7 of 12NP_689597.1A0A0S2Z626

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BBS5
ENST00000295240.8
TSL:1 MANE Select
c.584A>Gp.Asp195Gly
missense
Exon 7 of 12ENSP00000295240.3Q8N3I7-1
ENSG00000251569
ENST00000513963.1
TSL:2
c.584A>Gp.Asp195Gly
missense
Exon 7 of 16ENSP00000424363.1E9PBE3
BBS5
ENST00000392663.6
TSL:1
c.584A>Gp.Asp195Gly
missense
Exon 7 of 11ENSP00000376431.2Q8N3I7-2

Frequencies

GnomAD3 genomes
AF:
0.00183
AC:
279
AN:
152234
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000603
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0156
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00634
AC:
1593
AN:
251228
AF XY:
0.00440
show subpopulations
Gnomad AFR exome
AF:
0.000739
Gnomad AMR exome
AF:
0.0448
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000616
Gnomad OTH exome
AF:
0.00440
GnomAD4 exome
AF:
0.00132
AC:
1933
AN:
1459404
Hom.:
46
Cov.:
29
AF XY:
0.00104
AC XY:
754
AN XY:
726154
show subpopulations
African (AFR)
AF:
0.000419
AC:
14
AN:
33414
American (AMR)
AF:
0.0410
AC:
1833
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26096
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39606
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86176
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53410
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5756
European-Non Finnish (NFE)
AF:
0.0000198
AC:
22
AN:
1109918
Other (OTH)
AF:
0.00106
AC:
64
AN:
60310
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
98
195
293
390
488
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00183
AC:
279
AN:
152352
Hom.:
4
Cov.:
32
AF XY:
0.00179
AC XY:
133
AN XY:
74506
show subpopulations
African (AFR)
AF:
0.000601
AC:
25
AN:
41580
American (AMR)
AF:
0.0156
AC:
239
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68026
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
13
26
39
52
65
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000999
Hom.:
9
Bravo
AF:
0.00413
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.00450
AC:
546

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
1
1
not provided (2)
-
-
1
Bardet-Biedl syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.34
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Uncertain
0.010
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.45
T
Eigen
Uncertain
0.52
Eigen_PC
Uncertain
0.61
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.95
D
MetaRNN
Benign
0.011
T
MetaSVM
Uncertain
-0.28
T
MutationAssessor
Benign
1.8
L
PhyloP100
9.3
PROVEAN
Uncertain
-3.7
D
REVEL
Uncertain
0.36
Sift
Uncertain
0.0070
D
Sift4G
Benign
0.16
T
Polyphen
0.51
P
Vest4
0.66
MVP
0.88
MPC
0.64
ClinPred
0.027
T
GERP RS
5.8
Varity_R
0.58
gMVP
0.30
Mutation Taster
=52/48
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143191074; hg19: chr2-170350312; COSMIC: COSV54753568; COSMIC: COSV54753568; API